Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(1.90)
# 1,152
Out of 5,182 analysts
22
Total ratings
34.78%
Success rate
-0.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics | Maintains: Buy | $60 → $110 | $26.47 | +315.56% | 5 | Mar 25, 2026 | |
| GPCR Structure Therapeutics | Maintains: Buy | $114 → $100 | $45.33 | +120.60% | 4 | Mar 16, 2026 | |
| DYN Dyne Therapeutics | Maintains: Buy | $60 → $50 | $18.04 | +177.16% | 3 | Mar 3, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $37 | $22.30 | +65.92% | 2 | Feb 3, 2026 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $50 | $33.71 | +48.32% | 1 | Dec 15, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $1.60 | +1,150.00% | 3 | Nov 13, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $5.13 | +367.84% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $1.06 | +1,786.79% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $6.10 | +129.51% | 1 | Aug 15, 2025 |
Maze Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $60 → $110
Current: $26.47
Upside: +315.56%
Structure Therapeutics
Mar 16, 2026
Maintains: Buy
Price Target: $114 → $100
Current: $45.33
Upside: +120.60%
Dyne Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $60 → $50
Current: $18.04
Upside: +177.16%
ACADIA Pharmaceuticals
Feb 3, 2026
Reiterates: Buy
Price Target: $37
Current: $22.30
Upside: +65.92%
Stoke Therapeutics
Dec 15, 2025
Maintains: Buy
Price Target: $35 → $50
Current: $33.71
Upside: +48.32%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $1.60
Upside: +1,150.00%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $5.13
Upside: +367.84%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $1.06
Upside: +1,786.79%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $6.10
Upside: +129.51%